Cite
HARVARD Citation
Graf, N. et al. (2019). The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma. Journal of the European Academy of Dermatology and Venereology. pp. 686-692. [Online].